Trimedoxime bromide
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by DMacks (talk | contribs) at 23:55, 23 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 23:55, 23 June 2020 by DMacks (talk | contribs) (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB))
![]() | |
Clinical data | |
---|---|
Routes of administration | Intramuscular injection |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 2 hours (mean) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.276 ![]() |
Chemical and physical data | |
Formula | C15H18Br2N4O2 |
Molar mass | 446.143 g·mol−1 |
Trimedoxime bromide (INN), also known as dipyroxime or TMB-4, is an oxime used in the treatment of organophosphate poisoning.
References
Nervous system | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Circulatory system |
| ||||||||||||||
Other |
| ||||||||||||||
Emetic | |||||||||||||||
|
![]() | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |